What is the appropriate work‑up for nocturnal enuresis in a 23‑year‑old Black male with daytime urinary urgency, normal urinalysis, normal genital exam, strong urine stream, no hesitancy, and who is taking olanzapine (Zyprexa) and mirtazapine (Remeron)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Nocturnal Enuresis in a 23-Year-Old on Olanzapine and Mirtazapine

This patient's nocturnal enuresis is most likely medication-induced by olanzapine (Zyprexa), and the workup should focus on ruling out urinary retention and bladder outlet obstruction before attributing symptoms to the antipsychotic.

Immediate Diagnostic Steps

1. Bladder Diary (3-Day Frequency-Volume Chart)

Document the following specific parameters 1, 2:

  • Voided volumes (day and night) to calculate nocturnal polyuria index (>20-33% of 24-hour output during sleep is abnormal)
  • Number of nocturnal voids and their volumes (small volumes suggest overactive bladder; normal/large volumes suggest nocturnal polyuria)
  • Functional bladder capacity (largest single void)
  • Total 24-hour urine output to assess for polydipsia

This is critical because the patient's symptom of "emptying but returning 20 minutes later" suggests either incomplete emptying with overflow or detrusor overactivity 3.

2. Post-Void Residual (PVR) Measurement

Obtain bladder ultrasound immediately after voiding 1:

  • PVR >50 mL suggests incomplete emptying
  • PVR >200-300 mL indicates significant retention
  • This is essential because adult-onset nocturnal enuresis with daytime urgency can herald urinary retention and overflow incontinence 4

3. Uroflowmetry

Measure maximum flow rate and voiding pattern 1:

  • The patient reports "strong stream," but objective measurement is needed
  • Flow <10 mL/sec suggests outlet obstruction or detrusor underactivity
  • Repeat testing improves diagnostic accuracy

Critical Differential Considerations

Medication-Induced Etiology (Most Likely)

Olanzapine is a known cause of nocturnal enuresis through its anticholinergic and antihistaminic effects 5, 6. Mirtazapine also has anticholinergic properties but is less commonly implicated 5. The combination may be synergistic.

Key features suggesting medication cause:

  • Timing of symptom onset relative to medication initiation
  • Nocturnal-only enuresis with daytime urgency/frequency
  • Normal UA and genital exam

Urinary Retention with Overflow (Must Rule Out)

Adult-onset nocturnal enuresis without daytime incontinence can indicate severe bladder outlet obstruction 4. In the original study, 100% of such patients had prostatic/bladder neck obstruction, with 63% having hydronephrosis. However, this patient has daytime urgency, which modifies the presentation.

The "sensation of emptying but returning 20 minutes later" is concerning for:

  • High post-void residual with rapid refilling
  • Detrusor overactivity with impaired contractility (DHIC)

Overactive Bladder (OAB)

Daytime urgency with nocturnal enuresis fits OAB criteria 2, but medication effects must be excluded first.

Additional Workup Based on Initial Findings

If PVR is Elevated (>100 mL):

  1. Renal ultrasound to assess for hydronephrosis 1, 4
  2. Serum creatinine to evaluate renal function 1
  3. Consider urodynamic studies if obstruction suspected despite normal exam 3

If PVR is Normal but Symptoms Persist:

  1. Urodynamic studies may reveal:
    • Detrusor overactivity
    • Reduced nocturnal bladder capacity
    • Low bladder compliance 3

If Bladder Diary Shows Nocturnal Polyuria:

Evaluate for:

  • Sleep apnea
  • Cardiovascular disease (hypertension, heart failure)
  • Diabetes mellitus/insipidus
  • Chronic kidney disease 2, 7

Management Algorithm

First-Line: Address Medication Cause

Coordinate with psychiatry to consider:

  1. Dose reduction of olanzapine if clinically feasible 6
  2. Switching to alternative antipsychotic with lower anticholinergic burden (e.g., aripiprazole) 6
  3. Do NOT abruptly discontinue - taper gradually 5

Second-Line: Behavioral Interventions

  • Void immediately before bedtime
  • Restrict fluids 2-3 hours before sleep
  • Set alarm to void during night 6

Third-Line: Pharmacologic Treatment (if medication adjustment not possible)

Aripiprazole augmentation is first-line pharmacologic treatment for antipsychotic-induced enuresis 6. Desmopressin may be considered for refractory cases but requires sodium monitoring 6.

Critical Pitfalls to Avoid

  1. Do not assume benign etiology without measuring PVR - adult-onset nocturnal enuresis can indicate serious urological pathology requiring urgent intervention 4

  2. Do not overlook urinary retention - anticholinergic medications can cause retention with overflow that mimics OAB 5

  3. Do not start empiric OAB medications without completing workup - anticholinergics would worsen medication-induced retention

  4. Do not ignore the psychiatric medication context - coordinate any changes with mental health providers to prevent psychotic decompensation 6

Related Questions

What are the common causes and recommended evaluation for secondary nocturnal enuresis in adults?
What are the differential diagnoses for a single episode of nocturnal enuresis in a young woman?
What is the diagnosis and treatment approach for an adult patient with enuresis (involuntary urination), considering potential underlying conditions such as diabetes, neurological disorders, or sleep disorders?
In a 6-year-old girl with recent nocturnal enuresis, occasional daytime urinary incontinence, and current darifenacin therapy, what evidence‑based pediatric urology diagnostic steps (including detailed history, physical examination, urinalysis, 48–72 hour frequency‑volume diary, renal‑bladder ultrasound, uroflowmetry with post‑void residual and pelvic‑floor EMG) are recommended, when should further investigations such as voiding cystourethrogram, formal urodynamics, or spinal MRI be pursued, how should constipation and bladder‑bowel dysfunction be screened and managed, and is darifenacin evidence‑based or approved for use in this age group and should it be continued pending objective findings?
What is the treatment for adult nocturnal enuresis (bedwetting)?
Is it safe to give Mobic (meloxicam) 15 mg to a patient on dialysis who has hepatic encephalopathy?
Can an 86-year-old female long-term-care resident taking duloxetine (Cymbalta) 30 mg daily and levetiracetam (Keppra) for seizures be started on valproic acid (Depakote) for mood?
For an 86-year-old woman in long-term care who is taking duloxetine (Cymbalta) 30 mg twice daily and levetiracetam for seizures, should valproic acid be added for mood stabilization?
In a patient on dialysis with hepatic encephalopathy, is meloxicam 15 mg comparable to 400 mg or 800 mg of ibuprofen in analgesic potency?
In an 86-year-old woman in long-term care receiving duloxetine 30 mg twice daily and levetiracetam for seizures, should any additional pharmacologic mood-stabilizing agent be added?
In an 86-year-old long-term-care patient currently taking duloxetine 30 mg twice daily and levetiracetam, should aripiprazole (Abilify) be added as an adjunct for major depressive disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.